News
CrowdStrike’s Falcon Flex subscription model is accelerating multi-module adoption. Find out why CRWD stock is a Buy and my ...
XPO beat estimates on the top and bottom lines in its second-quarter report. After an earlier investment cycle, management ...
Key Points - Non-GAAP earnings per share were $0.74 for the fiscal second quarter ended June 30, 2025, beating estimates by $0.03 (non-GAAP). Revenue reached $1,140.4 million for the fiscal second ...
Q2 2025 Earnings Call Transcript August 1, 2025 Enbridge Inc. beats earnings expectations. Reported EPS is $0.47, ...
21h
Barchart on MSNThis Dividend King Just Issued a Tariff Warning. Is Its Reliable Yield Enough to Soften the Blow?Facing $1 billion in added tariff costs, Procter & Gamble plans to raise prices and lean on cost cuts, but its 70-year ...
Reddit crushed Q2 with soaring revenue, AI monetization, and user growth, but lofty valuation limits upside. Find out why ...
15h
24/7 Wall St. on MSN4 Warren Buffett Dividend Stocks You Can Buy and Hold Forever Crushed Q2 EarningsIf any investor has stood the test of time, it’s Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has ...
By Chioma Obinna Fidson Healthcare Plc, Nigeria’s leading pharmaceutical manufacturer, has announced the retirement of its ...
In terms of fundamentals, Pfizer currently boasts a market capitalization of $132 billion. Over the last twelve months, the ...
Social Islami Bank (SIBL) reported a consolidated loss of Tk321 crore for the April-June quarter of 2025, primarily due to a sharp decline in interest income amid a rise in non-performing loans (NPLs) ...
The company’s share price has surged 11% since early July, reaching Tk229.80. As a result, Square Pharma’s market cap rose by Tk1,959 crore to Tk20,370 crore, making it the second-highest valued firm ...
20hon MSN
Warren Buffett's company reported less than half as much profit in the second quarter as it took a $3.76 billion writedown on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results